All bills
H.R. 2592·119th Congress·House Bill

Aviation Medication Transparency Act of 2025

Ordered ReportedTrack

Latest action (15 Sep 2026): Ordered to be Reported (Amended) by Voice Vote.

What this bill does

The Aviation Medication Transparency Act of 2025 would require the Federal Aviation Administration to publicly publish and maintain, on its website, a list of medications and treatments that can safely be prescribed to pilots and other airmen seeking or holding FAA medical certification. The FAA would have one year from enactment to publish this list, developed in consultation with the Aeromedical Innovation and Modernization Working Group, air traffic controllers' union representatives, the largest pilots' union, and other relevant stakeholders. The list must be comprehensive, written in accessible language, given to airmen when they first apply for a license and medical certificate, and updated annually.

The bill primarily affects pilots and other certificated airmen, who would gain clearer public information about which medications are approved or prohibited for FAA medical certification, including a "Do Not Issue" list and estimated timeframes for stabilizing on approved medications. It also affects medical providers, who would be given a mechanism to contact the FAA with questions about the list, and the FAA itself, which would bear new publication and consultation responsibilities.

The bill was introduced in the House on April 2, 2025, referred to the Committee on Transportation and Infrastructure, and has since been ordered reported, as amended, by voice vote on September 15, 2026. It would next need to be considered by the full House, and if passed, by the Senate, before it could be sent to the President.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Official summary

The committees assigned to this bill sent it to the House or Senate as a whole for consideration on September 15, 2026.

Timeline

  1. 15 Sep 2026

    Ordered to be Reported (Amended) by Voice Vote.

Common questions

What does H.R. 2592 do?
The Aviation Medication Transparency Act of 2025 would require the Federal Aviation Administration to publicly publish and maintain, on its website, a list of medications and treatments that can safely be prescribed to pilots and other airmen seeking or holding FAA medical certification. The FAA would have one year from enactment to publish this list, developed in consultation with the Aeromedical Innovation and Modernization Working Group, air traffic controllers' union representatives, the largest pilots' union, and other relevant stakeholders. The list must be comprehensive, written in accessible language, given to airmen when they first apply for a license and medical certificate, and updated annually. The bill primarily affects pilots and other certificated airmen, who would gain clearer public information about which medications are approved or prohibited for FAA medical certification, including a "Do Not Issue" list and estimated timeframes for stabilizing on approved medications. It also affects medical providers, who would be given a mechanism to contact the FAA with questions about the list, and the FAA itself, which would bear new publication and consultation responsibilities. The bill was introduced in the House on April 2, 2025, referred to the Committee on Transportation and Infrastructure, and has since been ordered reported, as amended, by voice vote on September 15, 2026. It would next need to be considered by the full House, and if passed, by the Senate, before it could be sent to the President.
Has H.R. 2592 become law?
Not yet. As of 15 Sep 2026, H.R. 2592 is ordered reported.
Who sponsored H.R. 2592?
H.R. 2592 was sponsored by Rep. Sean Casten [D-IL6] (Democrat-IL), with 0 cosponsors.
What's the latest action on H.R. 2592?
Ordered to be Reported (Amended) by Voice Vote. (15 Sep 2026).

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.